Interstitial lung disease in rheumatoid arthritis.

Current Rheumatology Reports
Dana P Ascherman

Abstract

Rheumatoid arthritis (RA) is the most common systemic autoimmune disease in the United States, affecting 1% to 2% of the adult population. Although joints and synovium are the primary targets in this disorder, extra-articular manifestations involving the lungs can lead to significant morbidity and excess mortality. Among the various pulmonary complications that occur in RA, interstitial lung disease (ILD) is the most damaging, with effects ranging from subclinical inflammation/scarring to end-stage pulmonary fibrosis. New insights during the past several years have underscored the epidemiologic impact of clinically/functionally significant RA-associated ILD (RA-ILD) and have begun to identify factors contributing to the pathogenesis of this potentially devastating complication of RA. Despite these advancements, the complexity of RA-ILD and the lack of reliable predictors for disease progression highlight the need for improved biomarker development. Establishing such detailed molecular signatures will ultimately guide the application and timing of therapeutic agents that include immunomodulators as well as newly studied antifibrotic agents.

References

Oct 1, 1995·Annals of the Rheumatic Diseases·B CortetB Delcambre
Aug 1, 1997·American Journal of Respiratory and Critical Care Medicine·E GabbayF R Lake
May 15, 2002·Annals of the Rheumatic Diseases·J K DawsonD R Graham
May 29, 2004·Radiology·Nobuyuki TanakaDavid A Lynch
Nov 6, 2004·Respiratory Medicine·Fumiko KinoshitaToshihide Ogawa
Nov 9, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Suzanne NijenhuisWalther J vanVenrooij
Jun 2, 2006·Proceedings of the American Thoracic Society·Carlo Agostini, Carmela Gurrieri
Jun 20, 2006·Rheumatology·T BongartzE L Matteson
Aug 16, 2006·Rheumatology·A YoungUNKNOWN Early Rheumatoid Arthritis Study (ERAS) group
Jan 16, 2007·American Journal of Respiratory and Critical Care Medicine·Joo Hun ParkThomas V Colby
Aug 9, 2007·Proceedings of the American Thoracic Society·Kevin K Brown
Sep 4, 2007·Seminars in Respiratory and Critical Care Medicine·Kevin O LeslieJames Gruden
Sep 18, 2007·Best Practice & Research. Clinical Rheumatology·Sophia M Naz, Deborah P M Symmons
Oct 27, 2007·Antioxidants & Redox Signaling·Benjamin D BringardnerClay B Marsh
Oct 27, 2007·Scandinavian Journal of Rheumatology·Z M MetafratziS C Efremidis
Jan 30, 2008·Archives of Internal Medicine·Bernadette R GochuicoIvan O Rosas
Apr 5, 2008·Current Opinion in Rheumatology·Carlotta NanniniEric L Matteson
Nov 11, 2008·Annals of Diagnostic Pathology·R Nagarjun RaoJoseph F Tomashefski
Dec 2, 2008·Expert Opinion on Pharmacotherapy·Clive Kelly, Vadivelu Saravanan
Jan 9, 2009·Mucosal Immunology·M S Wilson, T A Wynn
Feb 12, 2009·The Journal of Rheumatology·Athanasios N GeorgiadisAlexandros A Drosos
Apr 2, 2009·The European Respiratory Journal·K M AntoniouN M Siafakas
Dec 10, 2009·The European Respiratory Journal·E J KimH R Collard
Mar 13, 2010·Rheumatology·Guy Brusselle

❮ Previous
Next ❯

Citations

May 21, 2013·Autoimmunity Reviews·Benedetta MariglianoAntonella Afeltra
Nov 10, 2013·BioMed Research International·Lorenzo CavagnaRoberto Caporali
Aug 29, 2013·Clinical & Developmental Immunology·Juan ChenDana Ascherman
Jul 3, 2015·Case Reports in Pulmonology·Abhinav AgrawalSyed Hasan Yusuf
Oct 8, 2015·Scientific Reports·Ting WangZong-An Liang
Dec 4, 2013·Scandinavian Journal of Rheumatology·H EnnisA Herrick
Jul 15, 2015·International Urology and Nephrology·Bülent HuddamMurat Duranay
Jun 16, 2015·American Journal of Respiratory and Critical Care Medicine·Rekha VijImre Noth
Mar 10, 2015·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Jun-Xiang Wang, Chuan-Guo Du
Oct 11, 2014·Arthritis & Rheumatology·Juan ChenDana P Ascherman
Nov 1, 2016·Current Rheumatology Reports·Lindsay B KelmensonKevin D Deane
Oct 28, 2016·Arthritis & Rheumatology·Jorge A Zamora-LegoffEric L Matteson
Dec 6, 2017·Expert Review of Clinical Immunology·Fabiola AtzeniPiercarlo Sarzi-Puttini
Mar 3, 2015·European Respiratory Review : an Official Journal of the European Respiratory Society·Megan ShawGanesh Raghu
Aug 1, 2013·Expert Review of Clinical Immunology·Fabiola AtzeniPiercarlo Sarzi-Puttini
Sep 1, 2019·Clinical Rheumatology·Isabel M McFarlaneStephen Anthony Waite
Feb 8, 2020·Immunological Reviews·M Kristen DemoruelleKevin D Deane
Jul 28, 2017·Rheumatology International·Dam KimYoon-Kyoung Sung
Aug 20, 2019·Journal of Cellular and Molecular Medicine·Yasuhiro TerasakiAkira Shimizu
Oct 8, 2020·Current Rheumatology Reports·Timothy M WilsonM Kristen Demoruelle
Dec 22, 2020·Autoimmunity Reviews·Alessandro ConfortiPaola Cipriani
Jul 16, 2021·Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders·Geetha Wickrematilake

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Internal Medicine
Bernadette R GochuicoIvan O Rosas
American Journal of Respiratory and Critical Care Medicine
J BehrG Fruhmann
The European Respiratory Journal
J C Grutters, R M du Bois
© 2021 Meta ULC. All rights reserved